Soleus Capital Management, L.P. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Soleus Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $490,840 - $702,896	-7,661 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $498,501 - $752,616	7,661 New	7,661 $657,000
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $826,560 - $1.09 Million	-14,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $406,140 - $1.04 Million	14,000 New	14,000 $1.02 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.